Alopecia, atopic dermatitis studies top dermatology, aesthetics reads for week

Research presented at Plastic Surgery The Meeting finding that cell-enriched fat may represent an alternative for treating androgenetic alopecia in men and women was among the most-read articles of the past week on Healio.com/Dermatology and Healio.com/Aesthetics.

Other widely read articles included study results in which researchers at the Icahn School of Medicine at Mount Sinai and Northwestern University’s Feinberg School of Medicine have identified the skin phenotype of atopic dermatitis in infants:

Cell-enriched fat may represent alternative for treating pattern hair loss

LOS ANGELES — Stromal vascular fraction-enhanced adipose transplantation to the scalp may represent a promising alternative to treating androgenetic alopecia in men and women, according to research presented at Plastic Surgery The Meeting.

““Fat grafting with or without stem cells may turn out to be an effective treatment for hair loss,” Joel A. Aronowitz, MD, a plastic surgeon in Los Angeles, told Healio.com, following his presentation. Read more

Early results with off-label use of Kybella mixed, plastic surgeon reports

LOS ANGELES — Off-label use of Kybella for treating fat in areas of the body beyond submental fullness has had mixed results thus far, according to a speaker at Plastic Surgery The Meeting.

Phil Haeck, MD, a plastic surgeon practicing in Seattle and a past president of the American Society of Plastic Surgeons, spoke during the Hot Topics in Plastic Surgery session about his experiences treating various areas of body fat with Kybella (deoxycholic acid, Allergan), which has been approved by the FDA for treating submental fat. He reported mixed results in the treatment areas. Read more

Skin phenotype of atopic dermatitis identified in infants

Researchers at the Icahn School of Medicine at Mount Sinai and Northwestern University’s Feinberg School of Medicine have identified the skin phenotype of atopic dermatitis in infants, according to a press release.

Amy S. Paller, MD
Amy S. Paller

Emma Guttman-Yassky, MD, PhD, professor of dermatology and immunology and vice chair of the department of dermatology at the Icahn School of Medicine, and Amy S. Paller, MD, the Walter J. Hamlin professor and chair of the department of dermatology at Northwestern, determined that the nonlesional skin of young children with early eczema is already highly abnormal with significant immune activation in a study published in the Journal of Allergy and Clinical Immunology. Read more

Mohs micrographic surgery may be used for melanoma in situ beyond excision margins

Mohs micrographic surgery was used effectively to treat melanoma in situ exceeding traditional excision margins of 5 mm, according to published study results.

Researchers examined the long-term outcomes of 882 primary or recurrent melanoma in situ tumors (mean patient age, 62 years; 52.4% male) located on the trunk or proximal extremity and treated with Mohs micrographic surgery (MMS), and compared the outcomes with those of historical controls. Read more

Histogen, Pineworld Capital team to market hair growth treatment in China

Histogen announced a licensing agreement with Pineworld Capital to develop and commercialize its proprietary hair stimulating complex in China, according to a press release.

Results from two company-sponsored and one investigator-initiated clinical trial showed the hair stimulating complex safely, statistically and cosmetically promoted significant hair growth, the release said. Read more

Research presented at Plastic Surgery The Meeting finding that cell-enriched fat may represent an alternative for treating androgenetic alopecia in men and women was among the most-read articles of the past week on Healio.com/Dermatology and Healio.com/Aesthetics.

Other widely read articles included study results in which researchers at the Icahn School of Medicine at Mount Sinai and Northwestern University’s Feinberg School of Medicine have identified the skin phenotype of atopic dermatitis in infants:

Cell-enriched fat may represent alternative for treating pattern hair loss

LOS ANGELES — Stromal vascular fraction-enhanced adipose transplantation to the scalp may represent a promising alternative to treating androgenetic alopecia in men and women, according to research presented at Plastic Surgery The Meeting.

““Fat grafting with or without stem cells may turn out to be an effective treatment for hair loss,” Joel A. Aronowitz, MD, a plastic surgeon in Los Angeles, told Healio.com, following his presentation. Read more

Early results with off-label use of Kybella mixed, plastic surgeon reports

LOS ANGELES — Off-label use of Kybella for treating fat in areas of the body beyond submental fullness has had mixed results thus far, according to a speaker at Plastic Surgery The Meeting.

Phil Haeck, MD, a plastic surgeon practicing in Seattle and a past president of the American Society of Plastic Surgeons, spoke during the Hot Topics in Plastic Surgery session about his experiences treating various areas of body fat with Kybella (deoxycholic acid, Allergan), which has been approved by the FDA for treating submental fat. He reported mixed results in the treatment areas. Read more

Skin phenotype of atopic dermatitis identified in infants

Researchers at the Icahn School of Medicine at Mount Sinai and Northwestern University’s Feinberg School of Medicine have identified the skin phenotype of atopic dermatitis in infants, according to a press release.

Amy S. Paller, MD
Amy S. Paller

Emma Guttman-Yassky, MD, PhD, professor of dermatology and immunology and vice chair of the department of dermatology at the Icahn School of Medicine, and Amy S. Paller, MD, the Walter J. Hamlin professor and chair of the department of dermatology at Northwestern, determined that the nonlesional skin of young children with early eczema is already highly abnormal with significant immune activation in a study published in the Journal of Allergy and Clinical Immunology. Read more

Mohs micrographic surgery may be used for melanoma in situ beyond excision margins

Mohs micrographic surgery was used effectively to treat melanoma in situ exceeding traditional excision margins of 5 mm, according to published study results.

Researchers examined the long-term outcomes of 882 primary or recurrent melanoma in situ tumors (mean patient age, 62 years; 52.4% male) located on the trunk or proximal extremity and treated with Mohs micrographic surgery (MMS), and compared the outcomes with those of historical controls. Read more

Histogen, Pineworld Capital team to market hair growth treatment in China

Histogen announced a licensing agreement with Pineworld Capital to develop and commercialize its proprietary hair stimulating complex in China, according to a press release.

Results from two company-sponsored and one investigator-initiated clinical trial showed the hair stimulating complex safely, statistically and cosmetically promoted significant hair growth, the release said. Read more